An angiographic assessment of alteplase: Double-bolus and front-loaded infusion regimens in myocardial infarction
- 31 October 1998
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 136 (4) , 741-748
- https://doi.org/10.1016/s0002-8703(98)70024-9
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- The Effects of Tissue Plasminogen Activator, Streptokinase, or Both on Coronary-Artery Patency, Ventricular Function, and Survival after Acute Myocardial InfarctionNew England Journal of Medicine, 1993
- TIMI perfusion grade 3 but not grade 2 results in improved outcome after thrombolysis for myocardial infarction. Ventriculographic, enzymatic, and electrocardiographic evidence from the TEAM-3 Study.Circulation, 1993
- Randomized angiographic trial of recombinant tissue-type plasminogen activator (alteplase) in myocardial infarctionJournal of the American College of Cardiology, 1992
- Improved thrombolysis in acute myocardial infarction with front-loaded administration of alteplase: Results of the rt-PA-APSAC patency study (TAPS)Journal of the American College of Cardiology, 1992
- Does thrombolysis in myocardial infarction (TIMI) perfusion grade 2 represent a mostly patent artery or a mostly occluded artery? Enzymatic and electrocardiographic evidence from the TEAM-2 studyJournal of the American College of Cardiology, 1992
- Improved infarct-related arterial patency after high dose, weight-adjusted, rapid infusion of tissue-type plasminogen activator in myocardial infarction: Results of a multicenter randomized trial of two dosage regimensJournal of the American College of Cardiology, 1990
- Improved thrombolysis with a modified dose regimen of recombinant tissue-type plasminogen activatorJournal of the American College of Cardiology, 1989
- THROMBOLYSIS WITH TISSUE PLASMINOGEN ACTIVATOR IN ACUTE MYOCARDIAL INFARCTION: NO ADDITIONAL BENEFIT FROM IMMEDIATE PERCUTANEOUS CORONARY ANGIOPLASTYThe Lancet, 1988
- Thrombolysis in myocardial infarction (TIMI): Comparative studies of coronary reperfusion and systemic fibrinogenolysis with two forms of recombinant tissue-type plasminogen activatorJournal of the American College of Cardiology, 1987
- A multicenter, randomized, placebo-controlled trial of a new form of intravenous recombinant tissue-type plasminogen activator (activase) in acute myocardial infarctionJournal of the American College of Cardiology, 1987